Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and a major driver of stroke, heart failure, and hospitalization. The Atrial Fibrillation session offers a comprehensive, practice-focused approach to understanding AF mechanisms, symptom patterns, and long-term complications. Participants will review how ectopic triggers, atrial remodeling, fibrosis, and coexisting cardiovascular disease interact to maintain AF. The session emphasizes practical assessment tools, including ECG, echocardiography, ambulatory monitoring, and risk scoring systems, to characterize patients and guide individualized treatment strategies.

Clinicians around the world frequently search for an cardiology conference to keep up with rapidly evolving evidence on stroke prevention, rhythm control, and catheter ablation. This session synthesizes current guidelines on anticoagulation, integrating CHA?DS?-VASc and bleeding risk assessment with patient preferences and clinical context. Attendees will explore rate and rhythm control strategies using beta-blockers, calcium-channel blockers, digoxin, and antiarrhythmic drugs, along with indications and expectations for catheter ablation. Special scenarios such as AF with heart failure, hypertrophic cardiomyopathy, post-surgical AF, and AF in athletes are discussed through case-based examples.

A key theme is viewing atrial fibrillation management as far more than simply controlling rhythm. Participants will learn how obesity, sleep apnea, hypertension, diabetes, and alcohol use contribute to AF burden and recurrence, and how structured risk-factor modification programs can dramatically improve outcomes. The session explores lifestyle interventions, integrated AF clinics, and multidisciplinary models that coordinate cardiology, primary care, sleep medicine, and allied health support. Emphasis is placed on shared decision-making and clear communication about treatment options, procedural risk, and realistic expectations.

The session concludes with a look toward the future: novel anticoagulants, ablation technologies, rhythm monitoring tools, and digital health solutions that support long-term AF care. Attendees will consider how wearables, remote monitoring, and AI-driven analytics may change the way AF is detected and tracked. By the end, participants will have a robust, holistic framework to evaluate AF patients, reduce stroke risk, relieve symptoms, and improve quality of life over the long term.